Articles with keyword chemotherapy
-
Metronomic chemotherapy: efficacy in real clinical practice
V.A. Chubenko, L.A. Zagorskaya, V.S. Chubenko, F.V. Moiseenko, N.Kh. Abduloeva, A.S. Zhabina, M.M. Kramchaninov, K.V. Shelekhova, A.A. Meldo, E.M. Zykov, A.A. Kudryavcev, E.V. Napolskaya, V.M. Moiseyenko
metronomic chemotherapy, stable disease, time to progression, toxicity.
-
Cancer resistance to chemotherapy – are all possibilities exhausted?
N.М. Volkov
malignant tumors, chemotherapy, cytostatics, resistance.
-
Intraperitoneal chemotherapy in patients with advanced ovarian cancer: phase 2 institutional study
A.S. Tyulyandina, V.М. Nechushkina, L.V. Cherkes, K.Y. Morkhov, A.A. Rumyantsev, I.A. Pokataev, E.V. Glazkova, E.R. Virshke, D.Y. Frantsev, K.I. Zhordania, Y.V. Bujdenok, R.K. Valiev, A.V. Petrovsky, Y.S. Sergeev, I.V. Panichenko, A.A. Bulanov, M.B. Stenina, S.A. Tyulyandin
ovarian cancer, intraperitoneal chemotherapy, intravenous chemotherapy, optimal cytoreduction, cisplatin, paclitaxel.
-
OLANZAPINE VERSUS APREPITANT IN PATIENTS RECEIVING HIGH-EMETOGENIC CHEMOTHERAPY: INTERIM ANALYSIS OF RANDOMIZED PHASE II TRIAL
A.A. Rumyantsev, E.V. Glazkova, R.Yu. Nasyrova, E.O. Ignatova, L.V. Chitia, A.S. Popova, Kh.Kh. Elsnukaeva, I.A. Pokataev, A.S. Tyulyandina, M.B. Stenina, M.A. Frolova, A.A. Bulanov, V.Yu. Fedyanin, O.V. Sekhina, A.A. Tryakin, S.A. Tjulandin
olanzapine, aprepitant, chemotherapy, supportive care, CINV, nausea, vomiting.
-
First line dosointensive chemotherapy for Disseminated ovarian cancer after non optimal Cyted reduction: Results of the phase ii study
A.A. Rumyantsev, A.S. Tyulyandina, I.A. Pokataev, K.Yu. Morkhov, V.M. Nechushkina, V.E. Nikulin, S.O. Nikogosyan, K.I. Zhordania, S.A. Tyulyandin
ovarian cancer, dose-dense chemotherapy, dose-intensive chemotherapy, suboptimal debulking, non-optimal debulking.
-
Long-lasting full remission after selective intra-arterial chemotherapy for recurrence of locally advanced oral mucosa carcinoma
I.P. Moshurov, A.N. Redkin, N.A. Znatkova, M.S. Olshansky, A.Yu. Shklyarov, A.V. Tsurikova, S.A. Stikina
squamous cell carcinoma of the head and neck, relapse of oral cavity cancer, chemoradiation, intra-arterial chemotherapy, chemoembolization.
-
FIFTEEN COURSES OF SELECTIVE INTRA-ARTERIAL CHEMOTHERAPY FOR RELAPSE OF CANCER OF THE ORAL MUCOSA IN ONE PATIENT
M.S. Olshansky, A.Yu. Shklyarov, Yu.S. Konstantinova, E.N. Suhochev, S.A. Stikina, A.N. Redkin
squamous cell carcinoma of the head and neck, relapse of oral cavity cancer, chemoradiation treatment, intraarterial chemotherapy.
-
Immunotherapy Resistance – Finding Solutions
M.Yu. Fedyanin
cancer, chemotherapy, immunotherapy, resistance.
-
Analysis of the work of the central chemotherapy drugs breeding department in the State Medical Institution «St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncological) named after N.P. Napalkov» 2014–2022
V.M. Moiseenko, A.S. Zhabina, F.V. Moiseenko, N.M. Volkov, V.V. Yegorenkov, R.A. Ranzhina, N.K. Abduloeva
Drugs, chemotherapy, cytostatics breeding, safety of staff, quality, control, workload reduction, saving.
-
Efficacy of neoadjuvant endocrine therapy in HR-positive/HER2-negative breast cancer: A review
N.K. Abduloeva, V.M. Moiseenko, F.V. Moiseenko, O.A. Skripko, M.V. Scriabin, R.A. Ryandjina
Neoadjuvant endocrine therapy, neoadjuvant chemotherapy.
-
What has changed in clinical oncology practice In 2019?
M.Y. Fedyanin
cancer, chemotherapy, immunotherapy, targeted therapy.
-
NEW APPROACHES TO ADJUVANT THERAPY OF MALIGNANT TUMORS
K.S. Titov, A.V. Krasnorutsky, A.M. Kazakov, D.A. Ryabchikov
adjuvant chemotherapy, breast cancer, colorectal cancer, melanoma, sarcoma.
-
Pending issues of standard approaches in oncology
A.A. Tryakin, M.Yu. Fedyanin, I.A. Pokataev, A.V. Petrovsky
clinical guidelines, standards of care, chemotherapy, oncology.
-
Combinations of immunotherapy and other drugs
V.A. Chubenko
Target therapy, chemotherapy, check-point inhibitors, overall survival.
-
MEDICAL ERRORS IN THE DIAGNOSIS AND TREATMENT OF MALIGNANT TROPHOBLASTIC TUMORS
Z.A. Gasanbekova, L.A. Meshcheryakova, S.A. Aliev, V.V. Kuznetsov
trophoblastic, tumors, choriocarcinoma, bladder skeleton, chorionic gonadotropin, chemotherapy.
-
BIOPSY OF THE LYMPH NODES IN BREAST CANCER
E.M. Bit-Sava, M.G. Anchabandze, M.A. Monogarova, V.M. Moiseyenko
biopsy of signaling lymph nodes, axillary lymphadenectomy, neoadjuvant chemotherapy.
-
MEDICAL TREATMENT OF TUMORS: WHAT NEED TO KNOW A PRAC TICAL ONCOLOGIST
V.A. Chubenko
chemotherapy, immunotherapy, target therapy, overall survival, treatment guidelines.
-
Anemia and thrombocytopenia induced by antitumor therapy
I.A. Koroleva
сancer-and chemotherapy-induced anaemia (CIA), intravenous iron, ferric carboxymaltose, erythropoesis-stimulating agents (ESAs), сhemotherapy induced thrombocytopenia (CIT).
-
Debulking surgery in oncogynecology
S.Ya. Maximov, I.V. Sobolev, A.S. Hadjimba, A.A. Ilin, E.D. Gershfeld, D.-K. Reyes Santiago
cytoreductive, debulking surgery, ovarian cancer, cervical cancer, endometrial cancer, chemotherapy, radiotherapy
-
Clinical management of peritoneal metastases from colorectal cancer
D. Baratti, Sh. Kusamura, M. Guaglio, M. Deraco
colorectal cancer, peritoneal metastasis, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, HIPEC, liver metastasis
-
PROMISING METHODS FOR THE TREATMENT OF METASTATIC BREAST CANCER
A.S. Zhabina
metastatic breast cancer, high-dose chemotherapy, metronome therapy, vaccine therapy, adoptive therapy.
-
RE-IRRADIATION THERAPY FOR RECURRENT BRAIN TUMORS
O.I. Shcherbenko, O.S. Regentova
brain tumors, relapses, radiation therapy, chemotherapy, medulloblastoma, ependymoma, glioma, brain stem tumor, radiation injuries.
-
Practical and theoretical issues of surgery in oncology
V.V. Egorenkov
surgical oncology, minimally invasive surgery, sentinel node biopsy, cytoreductive surgery, intraoperative chemotherapy, reconstructive surgery.
-
The most important results of clinical trials for breast cancer systemic therapy in 2021
S.A. Tjulandin, М.В. Stenina, М.А. Frolova
breast cancer, immunotherapy, endocrine therapy, chemotherapy, gene expression assay, BRCA1/2-associated breast cancer.
-
CHANGES IN NEO- AND ADJUVANT TREATMENT OF BREAST CANCER IN THE LAST 5 YEARS
M.B. Stenina, M.A. Frolova, D.Z. Kupchan, S.A. Tjulandin
early breast cancer, neo-adjuvant therapy, adjuvant therapy, radiotherapy, chemotherapy, hormonotherapy, anti-HER2 therapy, ovarian suppression.
-
Surgical decision making in treating patients with metastatic tumors. focus on surgical treatment of peritoneal carcinomatosis
O.E. Kalinin, V.V. Gushchin
peritoneal carcinomatosis, cytoreductive surgery, curative surgery, palliative surgery, hyperthermic intraperitoneal chemotherapy, HIPEC, stage IV cancer, metastatic disease
-
Clinical experience of afatinib application In non-cell lung cancer of lung. Ii line of therapy
L.M. Kogoniya, E.V. Markarova, G.A. Stashuk, V.E. Shikina
lung cancer, adenocarcinoma, non-small cell lung cancer, EGFR mutation, chemotherapy, targeted therapy, efficacy, elderly, side effects
-
Urgent issues of drug therapy and possible solutions
E.V. Karabina
precision oncology, effectiveness of immunotherapy of malignant tumors, effectiveness of chemotherapy of malignant tumors, recovery of patients with advanced cancer.